Package 66715-6580-2

{"route": ["ORAL"], "spl_id": "2969fd97-4d37-c1d4-e063-6394a90ab50e", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0094187378441", "0761706164433"], "unii": ["9D2RTI9KYH", "362O9ITL9D", "04JA59TNSJ", "495W7451VQ"], "rxcui": ["1110988"], "spl_set_id": ["cfab9b80-0580-4482-b6e3-0aab875b5797"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Lil' Drug Store Products, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 POUCH in 1 CARTON (66715-6580-2)  / 2 TABLET, COATED in 1 POUCH", "package_ndc": "66715-6580-2", "marketing_start_date": "20220801"}], "brand_name": "DayQuil Severe plus VapoCOOL Cold and Flu, CVP HEALTH", "product_id": "66715-6580_2969fd97-4d37-c1d4-e063-6394a90ab50e", "dosage_form": "TABLET, COATED", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "66715-6580", "generic_name": "Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride", "labeler_name": "Lil' Drug Store Products, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "DayQuil Severe plus VapoCOOL Cold and Flu, CVP HEALTH", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "325 mg/1"}, {"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "10 mg/1"}, {"name": "GUAIFENESIN", "strength": "200 mg/1"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20220801", "listing_expiration_date": "20261231"}